PD-L1 antibody (FITC)

Catalog No. ABIN7648460

The HEK-293F Cells Monoclonal anti-PD-L1 antibody has been validated for WB, FACS, IHC and ICC. It is suitable to detect PD-L1 in samples from Human.

Quick Overview for PD-L1 antibody (FITC) (ABIN7648460)

Target: PD-L1 (CD274 (PD-L1))

Reactivity: Human

Host: HEK-293F Cells

Clonality: Monoclonal

Conjugate: This PD-L1 antibody is conjugated to FITC

Application: Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunocytochemistry (ICC)

Product Details anti-PD-L1 Antibody (FITC)

Purpose: FITC-Linked Anti-Programmed Cell Death Protein 1 Ligand 1 (PDL1) Monoclonal Antibody

Purification: Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Isotype: IgG

Application Details

Application Notes: Western blotting: 0.2-2 μg/mL,1:500-5000 Immunohistochemistry: 5-20 μg/mL,1:50-200 Immunocytochemistry: 5-20 μg/mL,1:50-200 Optimal working dilutions must be determined by end user.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Store at 4°C, protected from prolonged exposure to light.

Target Details for PD-L1

Target: PD-L1 (CD274 (PD-L1))

Alternative Name: Programmed Cell Death Protein 1 Ligand 1

Background: CD274, PDCD1LG1, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1-LG1, Programed Death Ligand 1

UniProt: Q9NZQ7

Pathways: Cancer Immune Checkpoints